1 Finasteride Oral Tablet Market Overview
    1.1 Product Overview and Scope of Finasteride Oral Tablet
    1.2 Finasteride Oral Tablet Segment by Type
        1.2.1 Global Finasteride Oral Tablet Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 1mg Tablet
        1.2.3 5mg Tablet
    1.3 Finasteride Oral Tablet Segment by Application
        1.3.1 Global Finasteride Oral Tablet Sales Comparison by Application: (2022-2028)
        1.3.2 Benign Prostatic Hyperplasia
        1.3.3 Male Pattern Baldness
        1.3.4 Others
    1.4 Global Finasteride Oral Tablet Market Size Estimates and Forecasts
        1.4.1 Global Finasteride Oral Tablet Revenue 2017-2028
        1.4.2 Global Finasteride Oral Tablet Sales 2017-2028
        1.4.3 Finasteride Oral Tablet Market Size by Region: 2017 Versus 2021 Versus 2028
2 Finasteride Oral Tablet Market Competition by Manufacturers
    2.1 Global Finasteride Oral Tablet Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Finasteride Oral Tablet Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Finasteride Oral Tablet Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Finasteride Oral Tablet Manufacturing Sites, Area Served, Product Type
    2.5 Finasteride Oral Tablet Market Competitive Situation and Trends
        2.5.1 Finasteride Oral Tablet Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Finasteride Oral Tablet Players Market Share by Revenue
        2.5.3 Global Finasteride Oral Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Finasteride Oral Tablet Retrospective Market Scenario by Region
    3.1 Global Finasteride Oral Tablet Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Finasteride Oral Tablet Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Finasteride Oral Tablet Market Facts & Figures by Country
        3.3.1 North America Finasteride Oral Tablet Sales by Country
        3.3.2 North America Finasteride Oral Tablet Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Finasteride Oral Tablet Market Facts & Figures by Country
        3.4.1 Europe Finasteride Oral Tablet Sales by Country
        3.4.2 Europe Finasteride Oral Tablet Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Finasteride Oral Tablet Market Facts & Figures by Region
        3.5.1 Asia Pacific Finasteride Oral Tablet Sales by Region
        3.5.2 Asia Pacific Finasteride Oral Tablet Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Finasteride Oral Tablet Market Facts & Figures by Country
        3.6.1 Latin America Finasteride Oral Tablet Sales by Country
        3.6.2 Latin America Finasteride Oral Tablet Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Finasteride Oral Tablet Market Facts & Figures by Country
        3.7.1 Middle East and Africa Finasteride Oral Tablet Sales by Country
        3.7.2 Middle East and Africa Finasteride Oral Tablet Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Finasteride Oral Tablet Historic Market Analysis by Type
    4.1 Global Finasteride Oral Tablet Sales Market Share by Type (2017-2022)
    4.2 Global Finasteride Oral Tablet Revenue Market Share by Type (2017-2022)
    4.3 Global Finasteride Oral Tablet Price by Type (2017-2022)
5 Global Finasteride Oral Tablet Historic Market Analysis by Application
    5.1 Global Finasteride Oral Tablet Sales Market Share by Application (2017-2022)
    5.2 Global Finasteride Oral Tablet Revenue Market Share by Application (2017-2022)
    5.3 Global Finasteride Oral Tablet Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Merck
        6.1.1 Merck Corporation Information
        6.1.2 Merck Description and Business Overview
        6.1.3 Merck Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Merck Finasteride Oral Tablet Product Portfolio
        6.1.5 Merck Recent Developments/Updates
    6.2 Accord Healthcare UK
        6.2.1 Accord Healthcare UK Corporation Information
        6.2.2 Accord Healthcare UK Description and Business Overview
        6.2.3 Accord Healthcare UK Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Accord Healthcare UK Finasteride Oral Tablet Product Portfolio
        6.2.5 Accord Healthcare UK Recent Developments/Updates
    6.3 Relonchem
        6.3.1 Relonchem Corporation Information
        6.3.2 Relonchem Description and Business Overview
        6.3.3 Relonchem Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Relonchem Finasteride Oral Tablet Product Portfolio
        6.3.5 Relonchem Recent Developments/Updates
    6.4 Sandoz
        6.4.1 Sandoz Corporation Information
        6.4.2 Sandoz Description and Business Overview
        6.4.3 Sandoz Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Sandoz Finasteride Oral Tablet Product Portfolio
        6.4.5 Sandoz Recent Developments/Updates
    6.5 Teva Generics
        6.5.1 Teva Generics Corporation Information
        6.5.2 Teva Generics Description and Business Overview
        6.5.3 Teva Generics Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Teva Generics Finasteride Oral Tablet Product Portfolio
        6.5.5 Teva Generics Recent Developments/Updates
    6.6 Cipla
        6.6.1 Cipla Corporation Information
        6.6.2 Cipla Description and Business Overview
        6.6.3 Cipla Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Cipla Finasteride Oral Tablet Product Portfolio
        6.6.5 Cipla Recent Developments/Updates
    6.7 Dr. Reddy
        6.6.1 Dr. Reddy Corporation Information
        6.6.2 Dr. Reddy Description and Business Overview
        6.6.3 Dr. Reddy Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Dr. Reddy Finasteride Oral Tablet Product Portfolio
        6.7.5 Dr. Reddy Recent Developments/Updates
    6.8 Aurobindo Pharma
        6.8.1 Aurobindo Pharma Corporation Information
        6.8.2 Aurobindo Pharma Description and Business Overview
        6.8.3 Aurobindo Pharma Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Aurobindo Pharma Finasteride Oral Tablet Product Portfolio
        6.8.5 Aurobindo Pharma Recent Developments/Updates
    6.9 Henan Topfond
        6.9.1 Henan Topfond Corporation Information
        6.9.2 Henan Topfond Description and Business Overview
        6.9.3 Henan Topfond Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Henan Topfond Finasteride Oral Tablet Product Portfolio
        6.9.5 Henan Topfond Recent Developments/Updates
    6.10 Zhejiang CONBA Pharmaceutical
        6.10.1 Zhejiang CONBA Pharmaceutical Corporation Information
        6.10.2 Zhejiang CONBA Pharmaceutical Description and Business Overview
        6.10.3 Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Product Portfolio
        6.10.5 Zhejiang CONBA Pharmaceutical Recent Developments/Updates
    6.11 Shandong Renhetang Pharmaceutical
        6.11.1 Shandong Renhetang Pharmaceutical Corporation Information
        6.11.2 Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Description and Business Overview
        6.11.3 Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Product Portfolio
        6.11.5 Shandong Renhetang Pharmaceutical Recent Developments/Updates
    6.12 Guangdong Eashu Pharmacetical
        6.12.1 Guangdong Eashu Pharmacetical Corporation Information
        6.12.2 Guangdong Eashu Pharmacetical Finasteride Oral Tablet Description and Business Overview
        6.12.3 Guangdong Eashu Pharmacetical Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Guangdong Eashu Pharmacetical Finasteride Oral Tablet Product Portfolio
        6.12.5 Guangdong Eashu Pharmacetical Recent Developments/Updates
    6.13 Shanghai Shyndec Pharmaceutical Co.,Ltd.
        6.13.1 Shanghai Shyndec Pharmaceutical Co.,Ltd. Corporation Information
        6.13.2 Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Description and Business Overview
        6.13.3 Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Product Portfolio
        6.13.5 Shanghai Shyndec Pharmaceutical Co.,Ltd. Recent Developments/Updates
7 Finasteride Oral Tablet Manufacturing Cost Analysis
    7.1 Finasteride Oral Tablet Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Finasteride Oral Tablet
    7.4 Finasteride Oral Tablet Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Finasteride Oral Tablet Distributors List
    8.3 Finasteride Oral Tablet Customers
9 Finasteride Oral Tablet Market Dynamics
    9.1 Finasteride Oral Tablet Industry Trends
    9.2 Finasteride Oral Tablet Market Drivers
    9.3 Finasteride Oral Tablet Market Challenges
    9.4 Finasteride Oral Tablet Market Restraints
10 Global Market Forecast
    10.1 Finasteride Oral Tablet Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Finasteride Oral Tablet by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Finasteride Oral Tablet by Type (2023-2028)
    10.2 Finasteride Oral Tablet Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Finasteride Oral Tablet by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Finasteride Oral Tablet by Application (2023-2028)
    10.3 Finasteride Oral Tablet Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Finasteride Oral Tablet by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Finasteride Oral Tablet by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Finasteride Oral Tablet Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Finasteride Oral Tablet Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Finasteride Oral Tablet Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Finasteride Oral Tablet Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Finasteride Oral Tablet Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Finasteride Oral Tablet Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Finasteride Oral Tablet Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Finasteride Oral Tablet Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Finasteride Oral Tablet Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Finasteride Oral Tablet Manufacturing Sites and Area Served
    Table 11. Manufacturers Finasteride Oral Tablet Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Finasteride Oral Tablet by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Finasteride Oral Tablet as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Finasteride Oral Tablet Sales by Region (2017-2022) & (K Units)
    Table 16. Global Finasteride Oral Tablet Sales Market Share by Region (2017-2022)
    Table 17. Global Finasteride Oral Tablet Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Finasteride Oral Tablet Revenue Market Share by Region (2017-2022)
    Table 19. North America Finasteride Oral Tablet Sales by Country (2017-2022) & (K Units)
    Table 20. North America Finasteride Oral Tablet Sales Market Share by Country (2017-2022)
    Table 21. North America Finasteride Oral Tablet Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Finasteride Oral Tablet Revenue Market Share by Country (2017-2022)
    Table 23. Europe Finasteride Oral Tablet Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Finasteride Oral Tablet Sales Market Share by Country (2017-2022)
    Table 25. Europe Finasteride Oral Tablet Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Finasteride Oral Tablet Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Finasteride Oral Tablet Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Finasteride Oral Tablet Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Finasteride Oral Tablet Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Finasteride Oral Tablet Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Finasteride Oral Tablet Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Finasteride Oral Tablet Sales Market Share by Country (2017-2022)
    Table 33. Latin America Finasteride Oral Tablet Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Finasteride Oral Tablet Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Finasteride Oral Tablet Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Finasteride Oral Tablet Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Finasteride Oral Tablet Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Finasteride Oral Tablet Revenue Market Share by Country (2017-2022)
    Table 39. Global Finasteride Oral Tablet Sales by Type (2017-2022) & (K Units)
    Table 40. Global Finasteride Oral Tablet Sales Market Share by Type (2017-2022)
    Table 41. Global Finasteride Oral Tablet Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Finasteride Oral Tablet Revenue Share by Type (2017-2022)
    Table 43. Global Finasteride Oral Tablet Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global Finasteride Oral Tablet Sales (K Units) by Application (2017-2022)
    Table 45. Global Finasteride Oral Tablet Sales Market Share by Application (2017-2022)
    Table 46. Global Finasteride Oral Tablet Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Finasteride Oral Tablet Revenue Share by Application (2017-2022)
    Table 48. Global Finasteride Oral Tablet Price by Application (2017-2022) & (US$/Unit)
    Table 49. Merck Corporation Information
    Table 50. Merck Description and Business Overview
    Table 51. Merck Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. Merck Finasteride Oral Tablet Product
    Table 53. Merck Recent Developments/Updates
    Table 54. Accord Healthcare UK Corporation Information
    Table 55. Accord Healthcare UK Description and Business Overview
    Table 56. Accord Healthcare UK Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Accord Healthcare UK Finasteride Oral Tablet Product
    Table 58. Accord Healthcare UK Recent Developments/Updates
    Table 59. Relonchem Corporation Information
    Table 60. Relonchem Description and Business Overview
    Table 61. Relonchem Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. Relonchem Finasteride Oral Tablet Product
    Table 63. Relonchem Recent Developments/Updates
    Table 64. Sandoz Corporation Information
    Table 65. Sandoz Description and Business Overview
    Table 66. Sandoz Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. Sandoz Finasteride Oral Tablet Product
    Table 68. Sandoz Recent Developments/Updates
    Table 69. Teva Generics Corporation Information
    Table 70. Teva Generics Description and Business Overview
    Table 71. Teva Generics Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. Teva Generics Finasteride Oral Tablet Product
    Table 73. Teva Generics Recent Developments/Updates
    Table 74. Cipla Corporation Information
    Table 75. Cipla Description and Business Overview
    Table 76. Cipla Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. Cipla Finasteride Oral Tablet Product
    Table 78. Cipla Recent Developments/Updates
    Table 79. Dr. Reddy Corporation Information
    Table 80. Dr. Reddy Description and Business Overview
    Table 81. Dr. Reddy Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. Dr. Reddy Finasteride Oral Tablet Product
    Table 83. Dr. Reddy Recent Developments/Updates
    Table 84. Aurobindo Pharma Corporation Information
    Table 85. Aurobindo Pharma Description and Business Overview
    Table 86. Aurobindo Pharma Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. Aurobindo Pharma Finasteride Oral Tablet Product
    Table 88. Aurobindo Pharma Recent Developments/Updates
    Table 89. Henan Topfond Corporation Information
    Table 90. Henan Topfond Description and Business Overview
    Table 91. Henan Topfond Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. Henan Topfond Finasteride Oral Tablet Product
    Table 93. Henan Topfond Recent Developments/Updates
    Table 94. Zhejiang CONBA Pharmaceutical Corporation Information
    Table 95. Zhejiang CONBA Pharmaceutical Description and Business Overview
    Table 96. Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 97. Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Product
    Table 98. Zhejiang CONBA Pharmaceutical Recent Developments/Updates
    Table 99. Shandong Renhetang Pharmaceutical Corporation Information
    Table 100. Shandong Renhetang Pharmaceutical Description and Business Overview
    Table 101. Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 102. Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Product
    Table 103. Shandong Renhetang Pharmaceutical Recent Developments/Updates
    Table 104. Guangdong Eashu Pharmacetical Corporation Information
    Table 105. Guangdong Eashu Pharmacetical Description and Business Overview
    Table 106. Guangdong Eashu Pharmacetical Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 107. Guangdong Eashu Pharmacetical Finasteride Oral Tablet Product
    Table 108. Guangdong Eashu Pharmacetical Recent Developments/Updates
    Table 109. Shanghai Shyndec Pharmaceutical Co.,Ltd. Corporation Information
    Table 110. Shanghai Shyndec Pharmaceutical Co.,Ltd. Description and Business Overview
    Table 111. Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 112. Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Product
    Table 113. Shanghai Shyndec Pharmaceutical Co.,Ltd. Recent Developments/Updates
    Table 114. Production Base and Market Concentration Rate of Raw Material
    Table 115. Key Suppliers of Raw Materials
    Table 116. Finasteride Oral Tablet Distributors List
    Table 117. Finasteride Oral Tablet Customers List
    Table 118. Finasteride Oral Tablet Market Trends
    Table 119. Finasteride Oral Tablet Market Drivers
    Table 120. Finasteride Oral Tablet Market Challenges
    Table 121. Finasteride Oral Tablet Market Restraints
    Table 122. Global Finasteride Oral Tablet Sales Forecast by Type (2023-2028) & (K Units)
    Table 123. Global Finasteride Oral Tablet Sales Market Share Forecast by Type (2023-2028)
    Table 124. Global Finasteride Oral Tablet Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 125. Global Finasteride Oral Tablet Revenue Market Share Forecast by Type (2023-2028)
    Table 126. Global Finasteride Oral Tablet Sales Forecast by Application (2023-2028) & (K Units)
    Table 127. Global Finasteride Oral Tablet Sales Market Share Forecast by Application (2023-2028)
    Table 128. Global Finasteride Oral Tablet Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 129. Global Finasteride Oral Tablet Revenue Market Share Forecast by Application (2023-2028)
    Table 130. Global Finasteride Oral Tablet Sales Forecast by Region (2023-2028) & (K Units)
    Table 131. Global Finasteride Oral Tablet Sales Market Share Forecast by Region (2023-2028)
    Table 132. Global Finasteride Oral Tablet Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 133. Global Finasteride Oral Tablet Revenue Market Share Forecast by Region (2023-2028)
    Table 134. Research Programs/Design for This Report
    Table 135. Key Data Information from Secondary Sources
    Table 136. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Finasteride Oral Tablet
    Figure 2. Global Finasteride Oral Tablet Market Share by Type in 2021 & 2028
    Figure 3. 1mg Tablet Product Picture
    Figure 4. 5mg Tablet Product Picture
    Figure 5. Global Finasteride Oral Tablet Market Share by Application in 2021 & 2028
    Figure 6. Benign Prostatic Hyperplasia
    Figure 7. Male Pattern Baldness
    Figure 8. Others
    Figure 9. Global Finasteride Oral Tablet Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Finasteride Oral Tablet Market Size (2017-2028) & (US$ Million)
    Figure 11. Global Finasteride Oral Tablet Sales (2017-2028) & (K Units)
    Figure 12. Finasteride Oral Tablet Sales Share by Manufacturers in 2021
    Figure 13. Global Finasteride Oral Tablet Revenue Share by Manufacturers in 2021
    Figure 14. The Global 5 and 10 Largest Finasteride Oral Tablet Players: Market Share by Revenue in 2021
    Figure 15. Finasteride Oral Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 16. Global Finasteride Oral Tablet Sales Market Share by Region (2017-2022)
    Figure 17. Global Finasteride Oral Tablet Sales Market Share by Region in 2021
    Figure 18. Global Finasteride Oral Tablet Revenue Market Share by Region (2017-2022)
    Figure 19. Global Finasteride Oral Tablet Revenue Market Share by Region in 2021
    Figure 20. United States Finasteride Oral Tablet Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Canada Finasteride Oral Tablet Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Germany Finasteride Oral Tablet Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. France Finasteride Oral Tablet Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. U.K. Finasteride Oral Tablet Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Italy Finasteride Oral Tablet Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Russia Finasteride Oral Tablet Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. China Finasteride Oral Tablet Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Japan Finasteride Oral Tablet Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. South Korea Finasteride Oral Tablet Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. India Finasteride Oral Tablet Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Australia Finasteride Oral Tablet Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. China Taiwan Finasteride Oral Tablet Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Indonesia Finasteride Oral Tablet Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Thailand Finasteride Oral Tablet Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Malaysia Finasteride Oral Tablet Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Mexico Finasteride Oral Tablet Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Brazil Finasteride Oral Tablet Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Argentina Finasteride Oral Tablet Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Turkey Finasteride Oral Tablet Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Saudi Arabia Finasteride Oral Tablet Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. UAE Finasteride Oral Tablet Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Sales Market Share of Finasteride Oral Tablet by Type (2017-2022)
    Figure 43. Manufacturing Cost Structure of Finasteride Oral Tablet
    Figure 44. Manufacturing Process Analysis of Finasteride Oral Tablet
    Figure 45. Finasteride Oral Tablet Industrial Chain Analysis
    Figure 46. Channels of Distribution
    Figure 47. Distributors Profiles
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed